TORRENT PHARMACEUTICALS LTD. - 500420 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Neutral Torrent Pharma; target of Rs 2160: Motilal Oswal
Motilal Oswal recommended Neutral rating on Torrent Pharma with a target price of Rs 2160 in its research report dated December 07, 2023. TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copies of Newspaper cuttings in connection with transfer of shares to IEPF TORRENT PHARMACEUTICALS LTD. - 500420 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Outcome of Postal Ballot TORRENT PHARMACEUTICALS LTD. - 500420 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Scrutinizer''s Report on the Postal Ballot TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Torrent and Zydus sign licensing agreement for co-marketing Saroglitazar Mg, a critical treatment for chronic liver diseases in India TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Issue of Duplicate Share Certificates TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Credit Rating
Intimation of Credit Rating
Torrent Pharma price targets up, point to 12% upside
The average price target of brokerages compiled by Bloomberg is 2,159, implying an upside of 12% from Monday's closing.